JPY 918.0
(2.11%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 18.49 Billion JPY | -7.57% |
2022 | 20.01 Billion JPY | 9.87% |
2021 | 18.21 Billion JPY | 2.0% |
2020 | 17.85 Billion JPY | 44.85% |
2019 | 12.32 Billion JPY | 1.82% |
2018 | 12.1 Billion JPY | 25.1% |
2017 | 9.67 Billion JPY | 3.78% |
2016 | 9.32 Billion JPY | 10.43% |
2015 | 8.44 Billion JPY | 24.55% |
2014 | 6.78 Billion JPY | -15.82% |
2013 | 8.05 Billion JPY | -29.32% |
2012 | 11.39 Billion JPY | 45.65% |
2011 | 7.82 Billion JPY | 6.08% |
2010 | 7.37 Billion JPY | -7.89% |
2009 | 8 Billion JPY | 27.31% |
2008 | 6.29 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 3.21 Billion JPY | -33.46% |
2023 Q1 | 4.36 Billion JPY | 4.36% |
2023 Q4 | 4.83 Billion JPY | 11.43% |
2023 Q3 | 4.33 Billion JPY | -14.32% |
2023 FY | 18.49 Billion JPY | -7.57% |
2023 Q2 | 5.06 Billion JPY | 15.99% |
2022 Q2 | 5.31 Billion JPY | -1.05% |
2022 Q4 | 4.18 Billion JPY | -18.74% |
2022 FY | 20.01 Billion JPY | 9.87% |
2022 Q1 | 5.37 Billion JPY | 9.88% |
2022 Q3 | 5.14 Billion JPY | -3.2% |
2021 Q1 | 3.82 Billion JPY | -15.19% |
2021 Q2 | 5.04 Billion JPY | 31.94% |
2021 Q3 | 4.46 Billion JPY | -11.39% |
2021 Q4 | 4.88 Billion JPY | 9.45% |
2021 FY | 18.21 Billion JPY | 2.0% |
2020 Q1 | 4.01 Billion JPY | 17.93% |
2020 Q4 | 4.5 Billion JPY | -2.27% |
2020 FY | 17.85 Billion JPY | 44.85% |
2020 Q3 | 4.6 Billion JPY | -2.54% |
2020 Q2 | 4.72 Billion JPY | 17.78% |
2019 Q3 | 3.2 Billion JPY | 8.7% |
2019 FY | 12.32 Billion JPY | 1.82% |
2019 Q1 | 2.77 Billion JPY | -13.94% |
2019 Q2 | 2.94 Billion JPY | 6.15% |
2019 Q4 | 3.4 Billion JPY | 6.32% |
2018 FY | 12.1 Billion JPY | 25.1% |
2018 Q3 | 3.21 Billion JPY | 9.44% |
2018 Q4 | 3.22 Billion JPY | 0.31% |
2018 Q1 | 2.73 Billion JPY | 1.94% |
2018 Q2 | 2.93 Billion JPY | 7.6% |
2017 FY | 9.67 Billion JPY | 3.78% |
2017 Q4 | 2.67 Billion JPY | 13.2% |
2017 Q3 | 2.36 Billion JPY | 0.72% |
2017 Q2 | 2.34 Billion JPY | 2.77% |
2017 Q1 | 2.28 Billion JPY | -5.4% |
2016 Q1 | 2.57 Billion JPY | 15.89% |
2016 FY | 9.32 Billion JPY | 10.43% |
2016 Q2 | 2.25 Billion JPY | -12.26% |
2016 Q3 | 2.08 Billion JPY | -7.77% |
2016 Q4 | 2.41 Billion JPY | 16.09% |
2015 Q2 | 2.1 Billion JPY | -5.91% |
2015 Q3 | 1.88 Billion JPY | -10.41% |
2015 FY | 8.44 Billion JPY | 24.55% |
2015 Q1 | 2.23 Billion JPY | 27.59% |
2015 Q4 | 2.21 Billion JPY | 17.73% |
2014 FY | 6.78 Billion JPY | -15.82% |
2014 Q4 | 1.75 Billion JPY | 11.16% |
2014 Q3 | 1.57 Billion JPY | -7.87% |
2014 Q2 | 1.71 Billion JPY | -1.59% |
2014 Q1 | 1.73 Billion JPY | 11.99% |
2013 Q4 | 1.55 Billion JPY | -10.59% |
2013 Q1 | 3.06 Billion JPY | -4.34% |
2013 Q2 | 1.69 Billion JPY | -44.66% |
2013 Q3 | 1.73 Billion JPY | 2.32% |
2013 FY | 8.05 Billion JPY | -29.32% |
2012 Q3 | 4.87 Billion JPY | 210.06% |
2012 Q2 | 1.57 Billion JPY | -9.39% |
2012 Q1 | 1.73 Billion JPY | -38.47% |
2012 FY | 11.39 Billion JPY | 45.65% |
2012 Q4 | 3.2 Billion JPY | -34.28% |
2011 Q4 | 2.82 Billion JPY | 69.72% |
2011 FY | 7.82 Billion JPY | 6.08% |
2011 Q1 | 1.62 Billion JPY | -46.54% |
2011 Q2 | 1.71 Billion JPY | 5.7% |
2011 Q3 | 1.66 Billion JPY | -3.06% |
2010 FY | 7.37 Billion JPY | -7.89% |
2010 Q1 | 1.72 Billion JPY | -42.01% |
2010 Q2 | 1.37 Billion JPY | -20.6% |
2010 Q3 | 1.26 Billion JPY | -7.66% |
2010 Q4 | 3.03 Billion JPY | 139.76% |
2009 Q4 | 2.97 Billion JPY | 72.51% |
2009 Q1 | 1.84 Billion JPY | 0.0% |
2009 FY | 8 Billion JPY | 27.31% |
2009 Q2 | 1.48 Billion JPY | -19.51% |
2009 Q3 | 1.72 Billion JPY | 16.34% |
2008 FY | 6.29 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Kitanotatsujin Corporation | 9.38 Billion JPY | -97.144% |
Euglena Co., Ltd. | 34.45 Billion JPY | 46.307% |
BEAUTY GARAGE Inc. | 5.8 Billion JPY | -218.921% |
Axas Holdings Co.,Ltd. | 3 Billion JPY | -516.518% |
C.I. Medical Co.,Ltd. | 9 Billion JPY | -105.399% |
Kao Corporation | 438.95 Billion JPY | 95.786% |
Niitaka Co., Ltd. | 6.65 Billion JPY | -177.762% |
Rohto Pharmaceutical Co.,Ltd. | 117.23 Billion JPY | 84.222% |
Shiseido Company, Limited | 696.62 Billion JPY | 97.345% |
Lion Corporation | 160.09 Billion JPY | 88.445% |
Mandom Corporation | 29.51 Billion JPY | 37.315% |
Ivy Cosmetics Corporation | 1.72 Billion JPY | -972.13% |
Milbon Co., Ltd. | 24 Billion JPY | 22.924% |
Nippon Shikizai, Inc. | 2.31 Billion JPY | -700.181% |
Fancl Corporation | 61.61 Billion JPY | 69.98% |
KOSÉ Corporation | 189.85 Billion JPY | 90.257% |
Cota Co., Ltd. | 4.25 Billion JPY | -334.932% |
HABA Laboratories,Inc. | 8.21 Billion JPY | -125.208% |
C'bon Cosmetics Co.,Ltd. | 6.37 Billion JPY | -190.371% |
Pola Orbis Holdings Inc. | 119.68 Billion JPY | 84.544% |
Noevir Holdings Co., Ltd. | 31.54 Billion JPY | 41.35% |
Adjuvant Holdings Co.,Ltd. | 2.86 Billion JPY | -546.42% |
Almado, Inc. | 4.11 Billion JPY | -350.023% |
I-ne CO., LTD. | 17.86 Billion JPY | -3.545% |
Premier Anti-Aging Co., Ltd. | 15.96 Billion JPY | -15.897% |
Liberta Co.,Ltd. | 2.68 Billion JPY | -589.943% |
AXXZIA Inc. | 8.57 Billion JPY | -115.788% |
S.T. Corporation | 15.07 Billion JPY | -22.724% |
Kobayashi Pharmaceutical Co., Ltd. | 70.59 Billion JPY | 73.797% |
Earth Corporation | 57.25 Billion JPY | 67.691% |
Sagami Rubber Industries Co., Ltd. | 1.57 Billion JPY | -1077.67% |
Asahi Eito Holdings Co.,Ltd. | 1.29 Billion JPY | -1324.628% |
MTG Co., Ltd. | 33.26 Billion JPY | 44.386% |
TRANSACTION CO.,Ltd. | 4.57 Billion JPY | -304.204% |
SHOBIDO Corporation | 4.5 Billion JPY | -311.037% |
Artnature Inc. | 25.01 Billion JPY | 26.051% |
Pigeon Corporation | 34.72 Billion JPY | 46.732% |
Unicharm Corporation | 351.52 Billion JPY | 94.738% |
Paltac Corporation | 53.06 Billion JPY | 65.138% |
CB GROUP MANAGEMENT Co., Ltd. | 13.78 Billion JPY | -34.191% |